vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development and Commercialization of Azeliragon for Treatment of Cancer

Stock Information for vTv Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.